New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 27, 2014
18:23 EDTKND, AMED, GTIVKindred Healthcare sends letter to Gentiva Health board
Kindred (KND) CEO Paul Diaz sent the following letter to Gentiva Health (GTIV): "We are writing to you, and the entire board of directors of Gentiva, regarding the reports in the marketplace that Gentiva may be pursuing an acquisition of Amedisys (AMED). We are concerned that, while refusing to discuss Kindred’s highly attractive cash offer, the Gentiva board may be pursuing a course that would disenfranchise its shareholders through a value-destroying and highly levered transaction with Amedisys. We believe it is incumbent on the Gentiva board, in fulfilling its fiduciary duty to its shareholders, to sit down with Kindred immediately and explore our value-enhancing proposal before entering into any agreement that could impair the value of, or preclude, a Kindred-Gentiva combination. As you know, our all-cash offer of $14.50 per share represents a 70% premium to Gentiva’s closing share price on May 14, 2014 (the day prior to Kindred making its proposal public), and would deliver immediate and certain value to Gentiva shareholders. In addition, we have expressed a willingness to offer cash and stock in a structure that would allow Gentiva shareholders to participate further in the synergies and upside potential of the proposed combination (which many Gentiva shareholders have told us they would prefer). We have also indicated that we would be prepared to consider increasing the value of our offer if Gentiva were to commence discussions and demonstrate additional value. Even before the Amedisys reports were brought to our attention, we listened with interest to the remarks of Gentiva’s Chief Financial Officer, Eric Slusser, at the Wells Fargo Healthcare Conference, particularly his statements indicating that a vertically integrated post-acute care provider would be best positioned to deliver effective care in the long run. This is one of the many reasons why we believe the proposed combination of Kindred and Gentiva makes so much sense. A Kindred-Gentiva combination would offer the benefits of vertical integration and position our combined company to provide integrated post-acute care at lower cost to a much broader range of patients. As both Gentiva and Amedisys focus exclusively on home health and hospice care, such a combination would not similarly advance the interests of patients or position Gentiva at the forefront of changes to the U.S. healthcare delivery system. We note that Kindred has an outstanding track record of successfully integrating acquisitions, including most recently RehabCare and Senior Home Care. In contrast to Kindred, both Gentiva and Amedisys have experienced integration challenges in the past. We believe the combination of Kindred and Gentiva would have minimal execution risk and a high likelihood of swift and seamless integration. Kindred remains firmly committed to the proposed combination with Gentiva, but we take our responsibilities to our shareholders very seriously. If Gentiva were to move forward with any other transaction, Kindred would review the outstanding $14.50 cash offer and consider revising or withdrawing it. As we have stated repeatedly over the last six weeks, we would strongly prefer to work with the Gentiva board to reach a negotiated agreement. We have repeatedly requested meetings with you, and are prepared to meet with you and your advisors as soon as is practicable. We once again call upon your board to immediately commence good-faith discussions with Kindred, so that our companies can move forward with a combination that serves the interests of all our stakeholders."
News For KND;GTIV;AMED From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2015
17:51 EDTKND, GTIVS&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices
Subscribe for More Information
17:24 EDTGTIV, KNDANI Pharmaceuticals to replace Gentiva Health in S&P 600 as of 2/2 close
Subscribe for More Information
January 26, 2015
17:33 EDTKNDKindred Healthcare apponts Kent H. Wallace as COO
Kindred Healthcare has named Kent H. Wallace Executive VP and COO, effective February 2. Mr. Wallace will be a member of the company’s Executive Committee. Benjamin A. Breier, current COO, will become CEO on March 31, succeeding Paul J. Diaz, who will become Executive Vice Chairman of the Kindred Board of Directors.
January 22, 2015
16:17 EDTGTIV, KNDGentiva Health stockholders approve combination with Kindred Healthcare
Subscribe for More Information
16:06 EDTGTIV, KNDGentiva Health stockholders approve combo with Kindred Healthcare
Gentiva Health Services (GTIV) announced that all proposals necessary for the combination with Kindred Healthcare (KND) were approved by Gentiva’s stockholders at the company’s Special Meeting of Stockholders. Gentiva and Kindred expect to complete the transaction on February 2. As previously announced, on October 9, Kindred and Gentiva entered into a definitive agreement under which Kindred will combine with Gentiva for $14.50 per share in cash and 0.257 shares of Kindred common stock based upon an agreed upon fixed exchange ratio.
January 21, 2015
11:35 EDTGTIV, KNDGentiva Health to host special shareholder meeting
Subscribe for More Information
January 16, 2015
10:47 EDTKNDBofA/Merrill healthcare facilities analyst analyst/industry conference call
Healthcare Facilities & Managed Care Analyst Bressler discusses the legislative and regulatory outlook for the industry for 2015 on an Analyst/Industry conference call to be held on January 23 at 2 pm.
January 15, 2015
13:47 EDTAMEDAmedisys sees '15 impact from Medicare Home Health rule more moderate
Amedisys announced that it expects the impact of the 2015 Medicare Home Health Prospective Payment System Final Rule to be more moderate than previously anticipated. Previously, the company had disclosed that it expected an impact of -0.80% relative to 2014 Medicare pricing; however, after further analysis, the company now expects the 2015 pricing to be relatively unchanged from 2014.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use